“…Furthermore, the pharmaceutical activity of these oxygenated monoterpenes was also associated with aromatic compounds having other stimulant activities such as astringent, diuretic, and carminative (Al-Zereini et al, 2022). Terpenoid compounds are commonly found in plants, animals, and fungi consisting of two or more isoprene units (Campos-Xolalpa et al, 2018). This terpenoid compound consists of an ionone or chalcone framework, which has various pharmacological properties, one of which is a cytotoxic agent and anticancer (Lima et al, 2019).…”
Cardamom is one of the medicinal plants called perennial herbs from the Zingiberaceae family. Cardamom, with the scientific name Amomum compactum, contains various phytochemical compounds such as terpenoids, flavonoids, phenolics, tannins, sterols, and proteins that are pharmacologically useful as an anticancer, antioxidant, and have cytotoxic activity. Testing the total content of terpenoid compounds that affect the cytotoxic activity of A. compactum fruit using Box-Behnken Design with three independent variables (solvent ratio, ethanol concentration, and extraction time) has never been studied before. Thus, this study aimed to obtain the extraction optimization conditions on the total terpenoid content and cytotoxic activity using Artemia salina Leach larvae with the response surface method, namely Box-Behnken Design with Design Expert 13.0 application. Determination of the total terpenoid content of the A. compactum fruit extract was carried out based on the standard ursalic acid, and the cytotoxic activity was carried out using the Brine Shrimp Lethality Test (BSLT) method. The maximum total terpenoid obtained was 4.8970 mg UAE/g DW, and the minimum IC50 value was 38.8813 ppm. Optimal conditions for the extraction of A. compactum fruit obtained a combination of 1:8 mL/g solvent ratio, 50% ethanol concentration, and extraction time of 1 day with a desirability value of 0.772. Furthermore, the optimal extraction solution results from the Box-Behnken Design were verified and analyzed using a One-Sample T-Test. Using the Box-Behnken Design extraction optimization method, the content of terpenoid bioactive compounds with cytotoxic activity from A. compactum fruit can be optimally obtained.
“…Furthermore, the pharmaceutical activity of these oxygenated monoterpenes was also associated with aromatic compounds having other stimulant activities such as astringent, diuretic, and carminative (Al-Zereini et al, 2022). Terpenoid compounds are commonly found in plants, animals, and fungi consisting of two or more isoprene units (Campos-Xolalpa et al, 2018). This terpenoid compound consists of an ionone or chalcone framework, which has various pharmacological properties, one of which is a cytotoxic agent and anticancer (Lima et al, 2019).…”
Cardamom is one of the medicinal plants called perennial herbs from the Zingiberaceae family. Cardamom, with the scientific name Amomum compactum, contains various phytochemical compounds such as terpenoids, flavonoids, phenolics, tannins, sterols, and proteins that are pharmacologically useful as an anticancer, antioxidant, and have cytotoxic activity. Testing the total content of terpenoid compounds that affect the cytotoxic activity of A. compactum fruit using Box-Behnken Design with three independent variables (solvent ratio, ethanol concentration, and extraction time) has never been studied before. Thus, this study aimed to obtain the extraction optimization conditions on the total terpenoid content and cytotoxic activity using Artemia salina Leach larvae with the response surface method, namely Box-Behnken Design with Design Expert 13.0 application. Determination of the total terpenoid content of the A. compactum fruit extract was carried out based on the standard ursalic acid, and the cytotoxic activity was carried out using the Brine Shrimp Lethality Test (BSLT) method. The maximum total terpenoid obtained was 4.8970 mg UAE/g DW, and the minimum IC50 value was 38.8813 ppm. Optimal conditions for the extraction of A. compactum fruit obtained a combination of 1:8 mL/g solvent ratio, 50% ethanol concentration, and extraction time of 1 day with a desirability value of 0.772. Furthermore, the optimal extraction solution results from the Box-Behnken Design were verified and analyzed using a One-Sample T-Test. Using the Box-Behnken Design extraction optimization method, the content of terpenoid bioactive compounds with cytotoxic activity from A. compactum fruit can be optimally obtained.
“…Many efforts have been made to discover the potential therapeutic effects of diterpenes from Salvia species for cardiovascular disease . However, according to one estimate, among 700 isolated compounds of Salvia genus reported, only 100 terpenoids have been isolated from 24 Salvia species, and less than half of these showed cytotoxic activity against cancer cells, including nine sesquiterpenoids …”
Three new germacrane sesquiterpenoid-type
alkaloids with an unusual
Δ8-7,12-lactam moiety, glechomanamides A–C
(1–3), and two pairs of 7,12-hemiketal
sesquiterpenoid epimers (4a/b, 5a/b) were isolated from Salvia scapiformis. Their structures were elucidated by spectroscopic methods including
HRESIMS, IR, UV, and 1D and 2D NMR and also confirmed by single-crystal
X-ray diffraction analysis. The chemical transformation of compounds 1–5 in a solution environment was analyzed
by 2D NMR spectroscopy. The aza acetallactams (1–3) were stable in organic solvent, while single crystals of
the hemiacetal esters (4a/b, 5a/b) underwent a tautomeric equilibrium after being dissolved.
Single crystals of 4a, 4b, and 5a were obtained for the first time as their naturally occurring forms.
Glechomanamide B (2) exhibited antiangiogenic activity
by suppression of vascular endothelial growth factor (VEGF)-induced
tube formation through modulation of VEGF receptor 2 (VEGFR2)-mediated
signaling pathways in human umbilical vascular endothelial cells (HUVECs).
In addition, compound 2 also showed the significant suppression
of mRNA expression associated with glycolysis and angiogenesis biomarkers
in high glucose (30 mM)-induced HUVECs. These findings suggest that
compound 2 might be a potential lead compound candidate
for the management of diabetic retinopathy.
The last two decades have seen a dramatic shift in cannabis legislation around the world. Cannabis products are now widely available and commercial production and use of phytocannabinoid products is rapidly growing. However, this growth is outpacing the research needed to elucidate the therapeutic efficacy of the myriad of chemical compounds found primarily in the flower of the female cannabis plant. This lack of research and corresponding regulation has resulted in processing methods, products, and terminology that are variable and confusing for consumers. Importantly, the impact of processing methods on the resulting chemical profile of full spectrum cannabis extracts is not well understood. As a first step in addressing this knowledge gap we have utilized a combination of analytical approaches to characterize the broad chemical composition of a single cannabis cultivar that was processed using previously optimized and commonly used commercial extraction protocols including alcoholic solvents and super critical carbon dioxide. Significant variation in the bioactive chemical profile was observed in the extracts resulting from the different protocols demonstrating the need for further research regarding the influence of processing on therapeutic efficacy as well as the importance of labeling in the marketing of multi-component cannabis products.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.